bloomberg exit take polit tail risk tabl
michael bloomberg know anti-tobacco advoc ith bloomberg foundat fund sever anti-tobacco organ
campaign tobacco free inde stringent regul tobacco industri ere part bloomberg polici
propos last eek ith highli divid democrat polit field possibl bloomberg emerg
democrat nomine us presidenti elect schedul later year creat investor nervous
bloomberg emerg democrat front runner ould becom hard invest tobacco ould essenti
becom view us presidenti elect tail risk tabl
biden sudden turn fortun start ith emphat south carolina media outlet ashington
 ide report endors jame clyburn turn tide decis biden south carolina
led democrat establish ralli behind biden hich result pete buttigieg ami klobuchar drop
race endors biden result remark perform super tuesday ith biden inning
state ballot lead berni sander democrat deleg race ashington note right jame
clyburn take victori lap kingmak
 hy import tobacco
jame clyburn hous major hip influenti member black caucu revers
youth tobacco epidem act bill pass hous last eek clyburn ultim vote passag
bill also creat investor anxieti media outlet report conveni store new march mani
democrat ho vote oppos includ menthol cigarett concern provis target commun
color menthol cig disproportion use african american see
 ritten previous ill pass ill get consid senat ill certainli veto
 hite hous hich hite hous confirm last eek still one could creat bearish scenario democrat hite
hous ill becom law consid biden inning black vote think biden ould sensit
pass law perceiv target commun color
berni sander presid ill target lot industri healthcar base polici propos hasnt
specif polici propos tobacco
volatil tape mani compani cut guidanc think tobacco compani go report
acceler tangibl oper momentum us cig volum data first month run yoy declin much better
rang guid industri player ould highlight could lead suppli side issu global
us e-cig industri someth allud bat recent earn call ill compound pressur e-cig industri
alreadi brace pre-market tobacco applic pmta process hich ill commenc may ith stock trade
cheapli vs histori peer think investor go ow prefer pmi ow pt bat ow pt current level
cig volum data better nielsen feb
us smoker said survey smoke menthol cigarett past day
nation survey drug use
link previou research
altria/bat feb cig volum shipment vs nielsen
inc pmi grow ep post feb
imperi brand plc orsen ngp loss lead groundhog day feb
altria/bat jan cig volum shipment vs nielsen feb
inc last ep cut juul ritedow feb
british american tobacco plc rai us volum declin jan
altria/bat dec cig volum shipment vs nielsen jan
global consum stapl jan
global tobacco fda e-cig ban advantag bat juul flavor cigar ban jan
sw edish match address bearish pushback dec
japan tobacco japan close cigarillo tax gap dec
altria/bat report us cig volum bat e-cig begin grow rapidli dec
european consum stapl trump back aw ay ban e-cig flavor focu turn congress
altria/bat fda drop us cig nicotin reduct return menthol ban flavor cigar rulemak also get delay
altria/bat report us cig volum e-cig stall
imperi brand plc new chairperson dividend stabil still grow ing ep support stock
british american tobacco plc meet ith cfo
inc long journey rebuild trust
global tobacco juul uk europ financi oct
sw edish match zyn off-set flavor cigar oe pt sek oct
european consum stapl vape epidem fallaci e-cig flavour ban oct
european consum stapl pm-mo chang exchang ratio aug
inc iqo back track upgrad ow juli
european consum stapl smoke signal second deriv us volum turn posit atermelon blueberri
mentholet analys possibl implic menthol ban dec
smoke signal kick tyre ith juul sep
smoke signal juul disrupt come tobacco juli
imperi brand initi heat burn dow may
jame clyburn hous major hip influenti member black caucu revers
youth tobacco epidem act bill pass hous last eek clyburn ultim vote
gaurav jain herebi certifi view express research report accur reflect person view
subject secur issuer refer research report part compens ill directli
indirectli relat specif recommend view express research report
barclay capit inc and/or one affili seek busi ith compani cover research report
result investor aw firm may conflict interest could affect object report investor
consid report singl factor make invest decis
research report prepar hole part equiti research analyst base outsid us ho
registered/qualifi research analyst ith finra
barclay research produc invest bank barclay bank plc affili collect individu
barclay author contribut research report research analyst unless otherw ise indic public date
top report reflect local time report produc may differ releas date provid gmt
avail disclosur
 compani subject research report current import disclosur regard compani pleas
refer http //publicresearch barclay com altern send ritten request barclay research complianc seventh
avenu floor new york ny call
analyst respons prepar research report receiv compens base upon variou factor includ
firm total revenu portion hich gener invest bank activ profit revenu market
busi potenti interest firm invest client research ith respect asset class cover analyst
research analyst employ outsid us affili barclay capit inc registered/qualifi research analyst
 ith finra non-u research analyst may associ person barclay capit inc hich finra member
therefor may subject finra rule restrict commun ith subject compani public appear
trade secur held research analyst account
analyst regularli conduct site visit view materi oper cover compani barclay polici prohibit
accept payment reimburs cover compani travel expens visit
barclay research depart produc variou type research includ limit fundament analysi equity-link
analysi quantit analysi trade idea recommend contain one type barclay research may differ
contain type barclay research hether result differ time horizon methodolog otherw ise
order access barclay statement regard research dissemin polici procedur pleas refer
http //publicresearch barcap com/s/rd htm order access barclay research conflict manag polici statement pleas
refer http //publicresearch barcap com/s/cm htm
master limit partnership mlp pass-through entiti structur publicli list partnership tax purpos
distribut unit holder may treat return princip investor consult ow tax advisor
invest unit
valuat methodolog set price target altria base price-to-earnings valuat last tw decad altria trade
averag fw multipl higher cigarett volum declin regulatori uncertainti manag attempt sell us
busi p/core tobacco ep pressur multipl near term valu altria price-to-earnings add addit
valu per share juul crono get price target usd
risk may imped achiev barclay research valuat price target fda regul drastic
rate price target histori
prior intra-day chang may publish rate price target secur ere
histor stock price price target may adjust stock split dividend
valuat methodolog consid british american tobacco valuat use p/e-bas approach deriv
target multipl ith refer bat tobacco peer group make adjust busi mix leverag grow th
prospect appli multipl ep result round price target
risk may imped achiev barclay research valuat price target regulatori agenda
fda ill domin headlin everi month like creat period heighten volatil altria aggress ith
iqo could lead signific up-front invest disrupt market share equilibrium damag market profit
rate price target histori
prior intra-day chang may publish rate secur equal eight
adjust price target
histor stock price price target may adjust stock split dividend
unless otherw ise indic price sourc bloomberg reflect close price relev trade market hich
may last avail price time public
